Figure 4 — Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma

Navigate

Research Paper|Volume 16, Issue 3|pp. 2679–2701

Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma

Back to articleFigure 4(4 of 7)

100%

Figure 4.Correlation of CRGs expression with overall survival (A) and disease-free survival (B).

Figure 4 — Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma | Aging